Sg Americas Securities, LLC Allogene Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 46,967 shares of ALLO stock, worth $106,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46,967
Previous 13,316 252.71%
Holding current value
$106,615
Previous $31,000 325.81%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$2.08 - $3.5 $69,994 - $117,778
33,651 Added 252.71%
46,967 $132,000
Q2 2024

Jul 12, 2024
SELL
$2.23 - $4.38 $48,707 - $95,667
-21,842 Reduced 62.13%
13,316 $31,000
Q1 2024

May 06, 2024
SELL
$2.92 - $5.63 $53,511 - $103,175
-18,326 Reduced 34.26%
35,158 $157,000
Q4 2023

Jan 12, 2024
BUY
$2.28 - $3.5 $121,943 - $187,194
53,484 New
53,484 $172,000
Q1 2023

Apr 28, 2023
BUY
$4.92 - $8.21 $21,648 - $36,124
4,400 Added 37.38%
16,172 $80,000
Q4 2022

Feb 02, 2023
BUY
$5.62 - $11.11 $1,843 - $3,644
328 Added 2.87%
11,772 $74,000
Q3 2022

Oct 31, 2022
SELL
$10.32 - $17.28 $630,170 - $1.06 Million
-61,063 Reduced 84.22%
11,444 $124,000
Q2 2022

Jul 29, 2022
SELL
$6.78 - $12.28 $726,212 - $1.32 Million
-107,111 Reduced 59.63%
72,507 $827,000
Q1 2022

Apr 29, 2022
BUY
$7.65 - $15.29 $428,354 - $856,148
55,994 Added 45.29%
179,618 $1.64 Million
Q4 2021

Feb 07, 2022
BUY
$13.13 - $24.52 $325,230 - $607,360
24,770 Added 25.06%
123,624 $1.84 Million
Q3 2021

Nov 01, 2021
BUY
$21.01 - $27.64 $429,444 - $564,961
20,440 Added 26.07%
98,854 $2.54 Million
Q2 2021

Aug 12, 2021
SELL
$23.49 - $35.8 $84,376 - $128,593
-3,592 Reduced 4.38%
78,414 $2.05 Million
Q1 2021

May 13, 2021
SELL
$25.79 - $39.02 $559,694 - $846,812
-21,702 Reduced 20.93%
82,006 $2.9 Million
Q4 2020

Feb 04, 2021
BUY
$25.24 - $43.45 $2.03 Million - $3.5 Million
80,444 Added 345.79%
103,708 $2.62 Million
Q3 2020

Nov 09, 2020
SELL
$32.38 - $44.96 $232,099 - $322,273
-7,168 Reduced 23.55%
23,264 $877,000
Q2 2020

Jul 20, 2020
SELL
$18.39 - $54.04 $398,621 - $1.17 Million
-21,676 Reduced 41.6%
30,432 $1.3 Million
Q1 2020

Apr 30, 2020
BUY
$18.22 - $28.25 $535,868 - $830,860
29,411 Added 129.58%
52,108 $1.01 Million
Q4 2019

Jan 28, 2020
SELL
$24.82 - $31.4 $389,003 - $492,132
-15,673 Reduced 40.85%
22,697 $590,000
Q3 2019

Nov 04, 2019
BUY
$26.11 - $32.99 $1 Million - $1.27 Million
38,370 New
38,370 $1.05 Million

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email